Desmond Padhi

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Desmond Padhi, Graham Jang, Brian Stouch et al. · Journal of Bone and Mineral Research · 2010 · 776 citations

Sclerostin, Healthy Subjects, Immunology +18

A single-dose study of denosumab in patients with various degrees of renal impairment

Geoffrey A. Block, Henry G. Bone, Liang Fang et al. · Journal of Bone and Mineral Research · 2012 · 332 citations · Full text

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study

Desmond Padhi, Mark Allison, Alan Kivitz et al. · The Journal of Clinical Pharmacology · 2013 · 182 citations · Full text

Sclerostin, Immunology, Pharmacotherapy +17

Bioavailability and Metabolism of Mometasone Furoate following Administration by Metered‐Dose and Dry‐Powder Inhalers in Healthy Human Volunteers

Melton B. Affrime, Francis M. Cuss, Desmond Padhi et al. · The Journal of Clinical Pharmacology · 2000 · 97 citations

Asthma, Nutrition, Healthy Subjects +17

Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily

Robert Z. Harris, Desmond Padhi, Thomas Marbury et al. · American Journal of Kidney Diseases · 2004 · 83 citations

Hemodialysis, Renal Function, Hemodialysis Patients +10